PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Solid update. I like this part: "If Paradigm is successful in...

  1. 6,545 Posts.
    lightbulb Created with Sketch. 1967
    Solid update.

    I like this part:

    "If Paradigm is successful in obtaining TGA Provisional approval, Paradigm would be permitted to market and sell Zilosul for the treatment of osteoarthritis in Australia generating revenue as early as Q3 CY2020."
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.